researchers examined 1,714 samples over six months and found that just 39 per cent contained what they buyer thought they had been sold
.
.
.
.: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies."